ZA914322B - Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases - Google Patents
Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseasesInfo
- Publication number
- ZA914322B ZA914322B ZA914322A ZA914322A ZA914322B ZA 914322 B ZA914322 B ZA 914322B ZA 914322 A ZA914322 A ZA 914322A ZA 914322 A ZA914322 A ZA 914322A ZA 914322 B ZA914322 B ZA 914322B
- Authority
- ZA
- South Africa
- Prior art keywords
- leukotrienerelated
- pyridyl
- diseases
- treating
- benzoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53439790A | 1990-06-07 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA914322B true ZA914322B (en) | 1992-06-24 |
Family
ID=24129867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA914322A ZA914322B (en) | 1990-06-07 | 1991-06-06 | Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0593464A1 (enExample) |
| JP (1) | JPH07116150B2 (enExample) |
| KR (1) | KR930700102A (enExample) |
| CN (1) | CN1058015A (enExample) |
| AU (1) | AU655428B2 (enExample) |
| CA (1) | CA2083957A1 (enExample) |
| FI (1) | FI925545L (enExample) |
| HU (1) | HUT64747A (enExample) |
| IL (1) | IL98387A0 (enExample) |
| MA (1) | MA22195A1 (enExample) |
| MX (1) | MX26167A (enExample) |
| NZ (1) | NZ238426A (enExample) |
| PL (1) | PL290587A1 (enExample) |
| PT (1) | PT97913A (enExample) |
| TW (1) | TW221809B (enExample) |
| WO (1) | WO1991018601A1 (enExample) |
| ZA (1) | ZA914322B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06510786A (ja) * | 1991-09-19 | 1994-12-01 | スミスクライン・ビーチャム・コーポレイション | ロイコトリエン関連疾患治療用ピリジン化合物 |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| EP0649408A4 (en) * | 1992-06-30 | 1995-06-21 | Smithkline Beecham Corp | METHOD FOR THE PRODUCTION OF PHENYLTHIOMETHYLPYRIDINYLALKENOATS. |
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| GR1001409B (el) * | 1992-10-15 | 1993-11-30 | Smithkline Beecham Corp | Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια. |
| ES2065234B1 (es) * | 1992-10-27 | 1995-09-01 | Smithkline Beecham Corp | Compuestos para tratar enfermedades relacionadas con los leucotrienos. |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| EP0942903A1 (en) * | 1996-09-26 | 1999-09-22 | Novartis AG | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| EP1660094A4 (en) | 2003-08-26 | 2009-09-16 | Univ Colorado | INHIBITORS OF SERINE PROTEASE ACTIVITY AND USES THEREOF IN METHODS AND PREPARATIONS FOR TREATING BACTERIAL INFECTIONS |
| EP3812363B1 (en) * | 2018-06-22 | 2022-08-03 | Panasonic Holdings Corporation | Organic salt, hydroxy-radical sensor including same, and detection medium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
-
1991
- 1991-05-31 AU AU81896/91A patent/AU655428B2/en not_active Ceased
- 1991-05-31 CA CA002083957A patent/CA2083957A1/en not_active Abandoned
- 1991-05-31 WO PCT/US1991/003772 patent/WO1991018601A1/en not_active Ceased
- 1991-05-31 HU HU9203867A patent/HUT64747A/hu unknown
- 1991-05-31 JP JP3511468A patent/JPH07116150B2/ja not_active Expired - Lifetime
- 1991-05-31 FI FI925545A patent/FI925545L/fi not_active Application Discontinuation
- 1991-05-31 EP EP91911699A patent/EP0593464A1/en not_active Ceased
- 1991-05-31 KR KR1019920703091A patent/KR930700102A/ko not_active Abandoned
- 1991-06-03 MA MA22441A patent/MA22195A1/fr unknown
- 1991-06-05 IL IL98387A patent/IL98387A0/xx unknown
- 1991-06-06 ZA ZA914322A patent/ZA914322B/xx unknown
- 1991-06-06 NZ NZ238426A patent/NZ238426A/en unknown
- 1991-06-06 TW TW080104434A patent/TW221809B/zh active
- 1991-06-07 PT PT97913A patent/PT97913A/pt not_active Application Discontinuation
- 1991-06-07 MX MX2616791A patent/MX26167A/es unknown
- 1991-06-07 CN CN91104563A patent/CN1058015A/zh active Pending
- 1991-06-07 PL PL29058791A patent/PL290587A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU655428B2 (en) | 1994-12-22 |
| TW221809B (enExample) | 1994-03-21 |
| EP0593464A1 (en) | 1994-04-27 |
| HU9203867D0 (en) | 1993-03-29 |
| WO1991018601A1 (en) | 1991-12-12 |
| PL290587A1 (en) | 1992-08-24 |
| CA2083957A1 (en) | 1991-12-08 |
| CN1058015A (zh) | 1992-01-22 |
| MA22195A1 (fr) | 1992-04-01 |
| KR930700102A (ko) | 1993-03-13 |
| NZ238426A (en) | 1994-11-25 |
| FI925545A7 (fi) | 1992-12-07 |
| JPH07116150B2 (ja) | 1995-12-13 |
| FI925545A0 (fi) | 1992-12-07 |
| EP0593464A4 (en) | 1993-02-12 |
| PT97913A (pt) | 1992-03-31 |
| MX26167A (es) | 1994-02-28 |
| FI925545L (fi) | 1992-12-07 |
| IL98387A0 (en) | 1992-07-15 |
| JPH05507492A (ja) | 1993-10-28 |
| AU8189691A (en) | 1991-12-31 |
| HUT64747A (en) | 1994-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU907339D0 (en) | Process for treating diseases | |
| IL103126A0 (en) | 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| ZA914001B (en) | Essential fatty acid treatment | |
| HU9501923D0 (en) | Substituted azolone derivatives for treating diseases caused by helicobacter | |
| AP9200428A0 (en) | Compounds for treating leukotriene-related diseases | |
| ZA93190B (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
| IL98387A0 (en) | Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| IL98388A0 (en) | Benzoic acid derivatives for treating leukotriene-related diseases | |
| ZA914369B (en) | Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| EP0444156A4 (en) | Method for treating vascular diseases | |
| EP0421752A3 (en) | Substituted acrylamido-penicillanic acid derivatives | |
| CS22891A2 (en) | Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases | |
| HU9300544D0 (en) | Sulfobenzyil-substituted imidazolyl-propane acid derivatives | |
| IL97210A0 (en) | Process for the preparation of 7-amino-3-methoxymethyl-ceph-3-em-carboxylic acid | |
| ZA93125B (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
| NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
| HU905999D0 (en) | Process for the preparation of rodanido-isobutyric acid | |
| HUT57734A (en) | Process for producing pyrazaolecarboxylic acid derivatives | |
| ZA903999B (en) | Mevinic acid derivatives | |
| GB8809871D0 (en) | -amino-alkanoic acid derivative & processes | |
| NO924702D0 (no) | Pyridyl-benzosyrederivater for behandling av leukotrien-relaterte sykdommer | |
| EP0446925A3 (en) | Process for the preparation of beta-resorcylic acid derivatives | |
| ZA926938B (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| IE901971L (en) | Mevinic acid derivatives | |
| IE901047L (en) | Thienylacetic acid derivatives |